Altrazeal LIfe Sciences Inc
Addison, TX · CIK 0001168220 · Medtech · Private
Powder dressing formulation for wound care and accelerated healing
altrazeal.com →- Grants
- $1.3M
- 2 awards
- Sector median: 1
- Raised
- $15M
- 11 Form D · Sep 2023
- 37 months since last filing
- Contracts
- $3.0M
- 4 awards · Defense
- #174 of 4531 in medtech
- Patents
- 5
- 0 granted · 5 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20112013201520172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $2,210,000 | |
| Private capital raised | Form D · SEC | $400,000 | |
| Private capital raised | Form D · SEC | $58,250 | |
| Private capital raised | Form D · SEC | $87,000 | |
| Private capital raised | Form D · SEC | $42,600 | |
| Private capital raised | Form D · SEC | $500,000 | |
| Private capital raised | Form D · SEC | $1,550,225 | |
| Private capital raised | Form D · SEC | $1,714,000 | |
| Private capital raised | Form D · SEC | $5,500,000 | |
| Private capital raised | Form D · SEC | $690,000 | |
| Federal grant | Department of Defense · Phase I · Developing an Ideal First Use Agent to Prevent Sepsis in Trauma Wounds During Care Under Fire | $111,480 | |
| Federal contract | Department of Defense · Medical Research And Development Army SBIR Phase I Contract From Proposal #:A202-137-0553, Titled "developing An Ideal First Use Agent To Prevent Sepsis In Trauma Wounds During Care Under Fire" | $111,480 | |
| Federal grant | Department of Defense · Phase II · Developing an Ideal First Use Agent to Prevent Sepsis in Trauma Wounds During Care Under Fire | $1,155,968 | |
| Private capital raised | Form D · SEC | $2,216,621 | |
| Federal contract | Department of Defense · Dha SBIR Phi Topic DHA242-003 Proposal H2420030053 Title Innovative Adaptive Drug Delivery System Enhanced Neuroprotection Repair Traumatic Brain Injuries From Penetrating Trauma Open Skull Fractures In Low Resource Envir Med Randd EGS24000648 | $250,000 | |
| Federal contract | Department of Defense · Dha SBIR Sequential Phase II, Proposal No. H2S-0071, Titled: "developing An Ideal First Use Agent To Prevent Sepsis In Trauma Wounds During Care Under Fire." | $1,300,000 | |
| Federal contract | Department of Defense · SBIR Phase II Proposal Titled Innovative And Adaptive Drug Delivery System For Enhanced Neuroprotection And Repair In Traumatic Brain Injuries From Penetrating Trauma Or Open Skull Fractures In Low Resource Environments | $1,300,000 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 171 | JAN BIOTECH, INC. | $3.0M | — |
| 172 | MALCOVA INC | $3.0M | — |
| 173 | BERTEC CORP | $3.0M | — |
| 174 | Altrazeal LIfe Sciences Inc | $3.0M | $15M |
| 175 | TREACE MEDICAL CONCEPTS, INC. | $2.9M | $8.9M |
| 176 | CARINA MEDICAL LLC | $2.9M | — |
| 177 | PINMED, INC. | $2.9M | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Arindam BoseDirector
- Jeffrey DavisDirector
- Robert GoldrichDirector
- Kerry GrayDirector · Executive Officer
- Helmut KerschbaumerDirector · Executive Officer
- Klaus KuehneDirector
- Robert MandellDirector
- PK RamachandranExecutive Officer
- Bradley SacksDirector
- Dane ShacklefordExecutive Officer
- Anish ShahDirector · Executive Officer
- Vaidehi ShahDirector · Executive Officer
- Jeffrey StoneDirector
- Oksana TiedtDirector · Executive Officer
- Terrance WallbergDirector · Executive Officer
Patents
- Methods For Treating Traumatic Brain Injuriesapplication
- Shape-transforming Devices And Composites For Biological Site Stabilization And Therapeutic Deliveryapplication
- Hemostatic Compositions And Methods Using Composite Polymer Particlesapplication
- Compositions And Devices For Extended Efficacy And Customization Of Pharmaceutical Agents Through Composite Powder Combinations, Liquid Formulations, Kits, And Uses Thereofapplication
- Shape-transforming Devices For Stabilization Of Injuriesapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.